Ajanta Pharma (AJANTPHARM) Share Price Falls 3.02% Today: Price Action, Valuation and Peer Analysis

Ajanta Pharma Share Price fell to Rs 3,510.95 on 01 September 2026, down 3.02% or Rs 109.25 from the previous close of Rs 3,620.20. At the same snapshot, the company’s market capitalisation stood at Rs 44,472.92 crore, keeping the Large Cap pharmaceutical stock in focus on market screens.

The stock opened at Rs 3,603.30, which also marked the day’s high, and later declined to an intraday low of Rs 3,488.40. That pattern shows weakness developed after the open rather than through an early rebound. The supplied dataset confirms the price move, but it does not identify a company-specific trigger for the fall.

Even with the day’s decline, the company continues to trade at a P/E ratio of 39.86 and a P/B ratio of 9.31, while profitability metrics remain strong with ROE at 25.42% and ROCE at 32.67%. That combination of premium valuation and solid return ratios is why investors may look beyond the single-session move and compare the stock with its industry context and listed peers.

Ajanta Pharma (AJANTPHARM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,510.95
Previous Close	Rs 3,620.2
Today's Move	-Rs 109.25 (-3.02%)
Open	Rs 3,603.3
High	Rs 3,603.3
Low	Rs 3,488.4
Turnover	Rs 0.43 crore
Market Capitalisation	Rs 44,472.92 crore
Market Cap Category	Large Cap

Ajanta Pharma Share Price moved from Rs 3,620.20 in the previous session to Rs 3,510.95 in today’s snapshot, a fall of Rs 109.25. The stock started at Rs 3,603.30 and could not move above that level during the session, indicating sellers had the upper hand after the open. The subsequent slide to Rs 3,488.40 shows that intraday pressure extended well below both the opening price and the prior close.

Turnover at the time of the dataset stood at Rs 0.43 crore. While turnover alone does not explain the move, it helps place the session in context alongside the intraday range. For traders and short-term watchers, the notable levels from the supplied data are the open and high at Rs 3,603.30, the low at Rs 3,488.40, and the current traded price of Rs 3,510.95.

Because no verified company-specific catalyst is supplied, the day’s move is best read as a factual price event rather than a conclusion about business performance. That is why the next step is to evaluate the stock’s underlying metrics and compare them with its industry and peer set.

Ajanta Pharma (AJANTPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 44,472.92 crore
P/E Ratio	39.86x
P/B Ratio	9.31x
ROE	25.42%
ROCE	32.67%
EPS	Rs 90.82
Book Value Per Share	Rs 388.77
Dividend Yield	0.77%

The company’s fundamentals show a business with strong profitability metrics. ROE stands at 25.42% and ROCE at 32.67%, both robust in absolute terms. EPS is Rs 90.82, while book value per share is Rs 388.77. Dividend yield is 0.77% based on the supplied data.

Valuation, however, remains on the richer side. The stock trades at 39.86 times earnings and 9.31 times book value. Those figures do not automatically indicate overvaluation or undervaluation, but they do show that the market is placing a meaningful premium on the company relative to many businesses in the same industry.

That makes today’s fall notable. It is not occurring in a low-return business based on the available data. Instead, the move is taking place in a company that combines strong return ratios with elevated valuation multiples, a mix that often keeps investor attention focused on both quality and price discipline.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	39.86x
Benchmark Median P/E	30.92x
Benchmark Average P/E	48.02x
Benchmark P/E Range	3.87x to 667.16x
Company P/B Ratio	9.31x
Benchmark Median P/B	2.88x
Benchmark Average P/B	4.34x
Company ROE	25.42%
Benchmark Median ROE	11.81%
Benchmark Average ROE	11.21%
Company ROCE	32.67%
Benchmark Median ROCE	13.65%
Benchmark Average ROCE	13.76%
Company Market Capitalisation	Rs 44,472.92 crore
Benchmark Median Market Cap	Rs 683.05 crore
Benchmark Average Market Cap	Rs 14,252.9 crore

Ajanta Pharma belongs to Healthcare and the Pharmaceuticals & Drugs industry. The supplied benchmark covers 200 companies in the same industry, offering a broad comparison set for valuation, profitability, and size.

On valuation, the company’s P/E of 39.86 is above the industry median of 30.92 but below the average of 48.02. Its P/B of 9.31 is well above both the median of 2.88 and the average of 4.34. In simple terms, the stock is priced above typical industry levels on both earnings and book-value multiples.

Profitability tells a different story. ROE of 25.42% is materially higher than the industry median of 11.81% and average of 11.21%. ROCE of 32.67% is also far above the industry median of 13.65% and average of 13.76%. In market-cap terms, the company’s Rs 44,472.92 crore value is much larger than the industry median of Rs 683.05 crore and above the average of Rs 14,252.90 crore. This combination helps explain why the stock can command stronger attention even on a weak trading day.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,60,696.31	38.8	5.43	14.85	19.11
Divi's Laboratories	DIVISLAB	2,46,062.83	83.91	13.89	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,91,515.22	86.82	21.1	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,18,403.7	25.69	4.3	19.69	21.39
Cipla	CIPLA	1,14,554.33	33.94	3.25	11.83	16

Against the selected peer set, Ajanta Pharma is smaller by market value than Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, and Cipla. That places it below these major reference names on size, though it still remains a sizeable listed pharma company.

Its P/E of 39.86 is close to Sun Pharma’s 38.80, above Zydus Lifesciences at 25.69 and Cipla at 33.94, and well below Divi’s at 83.91 and Torrent at 86.82. Its P/B of 9.31 is higher than Sun Pharma, Zydus Lifesciences and Cipla, but lower than Divi’s and Torrent Pharmaceuticals.

Where Ajanta Pharma compares especially well is profitability. ROE of 25.42% is above Sun Pharma, Divi’s, Zydus Lifesciences and Cipla, while slightly below Torrent’s 26.76%. ROCE of 32.67% is stronger than all five peers listed in the comparison table. That helps explain why the stock can trade at a premium even though it is smaller than the biggest names in the space.

Why Investors Are Watching Ajanta Pharma

• Ajanta Pharma Share Price declined 3.02% today to Rs 3,510.95 from Rs 3,620.20.
• The stock opened at Rs 3,603.30, which was also the day’s high, and later slipped to Rs 3,488.40.
• Valuation remains above industry medians, with P/E at 39.86 and P/B at 9.31.
• ROE of 25.42% and ROCE of 32.67% are both ahead of industry averages.
• The company’s Rs 44,472.92 crore market cap keeps it relevant within Healthcare and Pharmaceuticals & Drugs tracking.

About Ajanta Pharma

Ajanta Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied market-cap data, it is substantially larger than the average company in its industry universe.

From a market-analysis perspective, the stock currently stands out for its mix of premium valuation and strong capital-efficiency metrics. That makes the current decline noteworthy, but not enough on its own to establish a broader conclusion without additional company-specific information.

Track Ajanta Pharma Share Price on Univest

Use Ajanta Pharma (AJANTPHARM) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

Investors tracking Ajanta Pharma Share Price can use Univest to follow live price moves, valuation ratios, peer comparison and broader market context in one place.

Frequently Asked Questions

Why is Ajanta Pharma Share Price falling today?

Ans.  The stock is down 3.02% today, falling Rs 109.25 from Rs 3,620.20 to Rs 3,510.95. The supplied data confirms the decline and intraday weakness, but it does not identify a company-specific catalyst behind the move.

What is Ajanta Pharma Share Price today?

Ans.  Ajanta Pharma Share Price today is Rs 3,510.95 at the supplied snapshot time. That is below the previous close of Rs 3,620.20. The previous close was Rs 3,620.2. The stock moved 3.02% lower during the session.

What does its valuation look like?

Ans.  The stock trades at a P/E ratio of 39.86 and a P/B ratio of 9.31. Both are above the industry medians of 30.92 and 2.88 respectively. The company trades at a P/E ratio of 39.86x.

How profitable is Ajanta Pharma compared with its industry?

Ans.  ROE is 25.42% and ROCE is 32.67%, both well above the Pharmaceuticals & Drugs industry medians of 11.81% and 13.65%. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.

How does Ajanta Pharma compare with key pharma peers?

Ans.  Its P/E is close to Sun Pharma’s, below Divi’s and Torrent, and above Zydus Lifesciences and Cipla. Its ROCE of 32.67% is stronger than all five peers in the supplied comparison set.

What should investors monitor next?

Ans.  Investors can monitor whether the stock holds above the day’s low of Rs 3,488.40, how its premium valuation compares with peers, and whether strong ROE and ROCE continue to support market positioning.